LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stem Cell and 3D Printing Generate Viable Tissue

By LabMedica International staff writers
Posted on 11 May 2017
Print article
Image: Three-dimensional (3D)-printed cartilage constructs growing in tissue culture (Photo courtesy of the University of Gothenburg).
Image: Three-dimensional (3D)-printed cartilage constructs growing in tissue culture (Photo courtesy of the University of Gothenburg).
A team of Swedish cell biologists combined three-dimensional (3D) bio-printing with advanced stem cell technology to create viable cultures of cartilage tissue that had cellular and mechanical properties similar to patients’ natural cartilage.

Cartilage lesions can progress into secondary osteoarthritis and cause severe clinical problems in numerous patients. To fill and cure such lesions, investigators at the University of Gothenburg developed a novel class of stem cells that could survive being injected by a three-dimensional printing method and then mature into functional cartilage tissue.

The investigators began with cartilage cells taken from patients undergoing knee surgery. These cells were then manipulated in a laboratory and transformed into induced pluripotent stem cells. The stem cells were expanded and encapsulated in a solution of nanofibrillated cellulose and printed into a structure using a three-dimensional (3D) bio-printer. Following printing, the stem cells were treated with growth factors that caused them to differentiate into cartilage tissue.

Much of the research effort involved finding a procedure to enable the cells to survive printing and multiply and a protocol that induced the cells to differentiate to form cartilage.

Results published in the April 6, 2017, online edition of the journal Scientific Reports revealed that pluripotency was initially maintained, and after five weeks, hyaline-like cartilaginous tissue with collagen type II expression and lacking tumorigenic Oct4 expression was observed in the three-dimensional (3D)-bio-printed constructs. Moreover, a marked increase in cell number within the cartilaginous tissue was detected by 2-photon fluorescence microscopy, indicating the importance of high cell densities in the pursuit of achieving good survival after printing.

“In nature, the differentiation of stem cells into cartilage is a simple process, but it is much more complicated to accomplish in a test tube. We are the first to succeed with it, and we did so without any animal testing whatsoever," said senior author Dr. Stina Simonsson, associate professor of cell biology at the University of Gothenburg. "We investigated various methods and combined different growth factors. Each individual stem cell is encased in nanocellulose, which allows it to survive the process of being printed into a three-dimensional (3D) structure. We also harvested media from other cells that contain the signals that stem cells use to communicate with each other - so called conditioned medium. In layman’s terms, our theory is that we managed to trick the cells into thinking that they are not alone.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more